CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Statement [Abstract]
Revenues	$ 0	$ 0	$ 0	$ 0
Costs and Expenses
Operating expenses	413,000	655,000	945,000	1,133,000
Research and development expenses	157,000	432,000	227,000	583,000
Loss before other expense	(570,000)	(1,087,000)	(1,172,000)	(1,716,000)
Other expense
Interest and financing expense	(271,000)	(371,000)	(435,000)	(2,024,000)
Net loss	$ (841,000)	$ (1,458,000)	$ (1,607,000)	$ (3,740,000)
Net loss per common share, basic and diluted	$ (0.00)	$ (0.00)	$ (0.01)	$ (0.01)
Weighted average common shares outstanding, basic and diluted	314,950,397	293,284,367	313,007,039	279,658,273